Cranbrook Wealth Management, LLC Amgen Inc Transaction History

Cranbrook Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $32,232 - $35,657	-147 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $24,462 - $27,994	-123 Reduced 45.56%	147 $33,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $5,306 - $6,217	25 Added 10.2%	270 $57,000
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $15,883 - $17,621	-68 Reduced 21.73%	245 $60,000
Q1 2021 May 06, 2021	BUY	$221.91 - $258.6 $15,089 - $17,584	68 Added 27.76%	313 $78,000
Q4 2017 Feb 07, 2018	BUY	$168.79 - $188.59 $7,595 - $8,486	45 Added 22.5%	245 $43,000
Q2 2017 Aug 10, 2017	BUY	N/A	200	200 $34,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Cranbrook Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cranbrook Wealth Management, LLC with notifications on news.